STEPHEN PAPPAS

Concepts (69)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatorenal Syndrome
12
2025
31
2.660
Why?
Vasoconstrictor Agents
11
2025
136
1.160
Why?
Lypressin
9
2025
17
0.930
Why?
Hepatitis B
1
2021
171
0.620
Why?
Duty to Warn
1
2019
2
0.580
Why?
Professional Impairment
1
2019
3
0.580
Why?
Alcoholic Intoxication
1
2019
15
0.570
Why?
Confidentiality
1
2019
108
0.540
Why?
Hepatitis C Antibodies
1
2017
27
0.530
Why?
Kidney Function Tests
2
2017
135
0.520
Why?
Alcoholism
1
2019
244
0.480
Why?
Diagnostic Tests, Routine
1
2017
129
0.480
Why?
Hepacivirus
1
2017
273
0.460
Why?
Albumins
6
2023
87
0.420
Why?
Liver Cirrhosis
5
2023
903
0.230
Why?
Acute Kidney Injury
2
2025
705
0.230
Why?
Bradycardia
1
2025
58
0.220
Why?
Chemical and Drug Induced Liver Injury
1
2026
157
0.210
Why?
Liver Transplantation
3
2023
1147
0.200
Why?
Respiratory Insufficiency
2
2022
247
0.190
Why?
Hepatitis, Alcoholic
1
2023
30
0.190
Why?
Multiple Sclerosis
1
2026
395
0.180
Why?
Hepatitis B Antibodies
1
2021
24
0.170
Why?
Arrhythmias, Cardiac
1
2025
482
0.170
Why?
Hepatitis B Vaccines
1
2021
49
0.170
Why?
Protein Kinase Inhibitors
1
2026
633
0.170
Why?
Acute-On-Chronic Liver Failure
1
2022
74
0.170
Why?
Hepatitis B virus
1
2021
133
0.160
Why?
Liver Cirrhosis, Alcoholic
1
2019
38
0.140
Why?
Safety
1
2019
215
0.140
Why?
Hepatic Encephalopathy
1
2019
83
0.140
Why?
Humans
17
2026
131163
0.130
Why?
Drug Therapy
1
2017
85
0.120
Why?
Health Personnel
1
2021
541
0.120
Why?
Alcohol Drinking
1
2019
341
0.120
Why?
Self Report
1
2019
554
0.110
Why?
Patient Education as Topic
1
2019
464
0.110
Why?
Interdisciplinary Communication
1
2016
129
0.110
Why?
Systemic Inflammatory Response Syndrome
1
2016
208
0.110
Why?
Surgical Procedures, Operative
1
2017
225
0.110
Why?
Interprofessional Relations
1
2016
149
0.110
Why?
Hepatitis C
1
2017
381
0.100
Why?
Information Dissemination
1
2016
194
0.100
Why?
Metabolomics
1
2017
501
0.100
Why?
Gastrointestinal Diseases
1
2016
343
0.090
Why?
Clinical Trials, Phase III as Topic
2
2025
80
0.090
Why?
Disease Progression
1
2017
2200
0.080
Why?
Renal Replacement Therapy
2
2023
172
0.080
Why?
Treatment Outcome
6
2023
12936
0.080
Why?
Biomarkers
1
2019
3385
0.070
Why?
Physicians
1
2016
635
0.070
Why?
Double-Blind Method
2
2021
1626
0.060
Why?
Randomized Controlled Trials as Topic
2
2025
1267
0.060
Why?
Canada
2
2016
327
0.060
Why?
Middle Aged
6
2025
28601
0.060
Why?
Drug Therapy, Combination
2
2017
1173
0.050
Why?
Infusions, Intravenous
1
2021
531
0.040
Why?
Male
6
2025
64957
0.040
Why?
Female
6
2025
70963
0.040
Why?
Aged
3
2025
21025
0.030
Why?
Combined Modality Therapy
1
2021
1216
0.030
Why?
Placebos
1
2016
223
0.030
Why?
Survival Rate
1
2020
2114
0.030
Why?
Adult
3
2025
31282
0.030
Why?
Survival Analysis
1
2016
1483
0.020
Why?
Prognosis
1
2020
4886
0.020
Why?
Kidney
1
2016
1282
0.020
Why?
United States
1
2016
12072
0.010
Why?
Retrospective Studies
1
2016
17753
0.010
Why?
PAPPAS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_